Department of Nursing, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 06974, Korea.
Int J Environ Res Public Health. 2020 Nov 20;17(22):8635. doi: 10.3390/ijerph17228635.
Hope is essential in rehabilitating persons with schizophrenia, though scales to measure hope are not appropriate for this population. The purpose of this cross-sectional study was to identify the psychometric properties of the Schizophrenia Hope Scale-9 (SHS-9) using data from 83 people with schizophrenia in four mental health centers and 762 healthy persons from two universities in South Korea. The total SHS-9 score is calculated by adding all items' scores and ranges from 0 to 18. The mean (standard deviation) SHS-9 score of the participants with schizophrenia and healthy participants was 11.53 (SD = 4.78) and 14.78 (SD = 3.19), respectively. Lower scores indicate a lower level of hope. The Cronbach's alpha coefficient was 0.92 with a four-week test-retest reliability of 0.89. Criterion-related construct validity was established by examining the correlation between the SHS-9 and the State-Trait Hope Inventory scores. Divergent validity was identified through a negative relationship of SHS-9 with the Beck Hopelessness Scale. In persons with schizophrenia and healthy college students, Bartlett's test of sphericity yielded χ = 465.03 ( < 0.001) and χ2 = 2679.24 ( < 0.001) respectively. The values of the Kaiser-Meyer-Olkin (KMO) measure of sampling adequacy were 0.89 and 0.90, respectively. The construct validity of the SHS-9 was confirmed through principal component analysis with extraction methods, which resulted in a one-factor solution, accounting for 61.83% of the total item variance. This study provides evidence for the validity and reliability of the SHS-9; therefore, it could be used to study the relationships between hope and other variables (e.g., depression and recovery) in persons with schizophrenia and measure the effect of psychosocial interventions on their hope.
希望是精神分裂症患者康复的关键,但用于评估希望的量表并不适用于这一人群。本横断面研究的目的是使用来自韩国四家心理健康中心的 83 名精神分裂症患者和两所大学的 762 名健康对照者的数据,确定精神分裂症希望量表-9(SHS-9)的心理测量特性。总 SHS-9 评分通过将所有项目的得分相加得出,范围为 0 至 18。精神分裂症患者和健康参与者的 SHS-9 总分均值(标准差)分别为 11.53(4.78)和 14.78(3.19)。较低的分数表示希望水平较低。Cronbach's α 系数为 0.92,四周重测信度为 0.89。通过检验 SHS-9 与状态-特质希望量表得分之间的相关性,建立了效标关联结构效度。通过 SHS-9 与贝克绝望量表之间的负相关关系,确定了区分效度。在精神分裂症患者和健康大学生中,Bartlett 球形检验的 χ 值分别为 465.03(<0.001)和 χ2=2679.24(<0.001)。Kaiser-Meyer-Olkin(KMO)抽样充分性测量值分别为 0.89 和 0.90。通过提取方法的主成分分析证实了 SHS-9 的结构效度,得到一个因素解决方案,占总项目方差的 61.83%。本研究为 SHS-9 的有效性和可靠性提供了证据;因此,它可以用于研究精神分裂症患者希望与其他变量(如抑郁和康复)之间的关系,并衡量心理社会干预对其希望的影响。